TipRanks
Go Ultimate55% OFF

Nathalie Dubois-Stringfellow Insider Profile

4 Followers

Nathalie Dubois-Stringfellow, SVP-CHIEF DEVELOPMENT OFFICER at Sangamo Therapeutics, holds 328.73K shares in Sangamo Therapeutics (Ticker: SGMOQ).

Nathalie Dubois-Stringfellow's Trading History

SGMOQ
Sangamo Therapeutics
May 27, 2026SVP-CHIEF DEVELOPMENT OFFICERUninformative Sell686.12$38.13K
SGMOQ
Insider Shares: 328.73K (0.08%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 27, 2026Uninformative Sell$686.124,036$0.17―
Apr 23, 2026Informative Sell$86.49K345,942$0.25―
Feb 26, 2026Uninformative Sell$5.81K12,354$0.47―
Feb 26, 2026Uninformative Sell$969.612,063$0.47―
Jan 26, 2026Uninformative Sell$14.30K36,676$0.39―

You May Also Like

Nathalie Dubois-Stringfellow insider profile FAQ

What stocks does Nathalie Dubois-Stringfellow hold?
Nathalie Dubois-Stringfellow holds: SGMOQ stocks.
What was Nathalie Dubois-Stringfellow’s latest transaction?
Nathalie Dubois-Stringfellow’s latest transaction was an Uninformative Sell of $686.12.
What is Nathalie Dubois-Stringfellow's role in Sangamo Therapeutics?
Nathalie Dubois-Stringfellow's role in Sangamo Therapeutics is SVP-CHIEF DEVELOPMENT OFFICER.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.